MED19 抗体
Quick Overview for MED19 抗体 (ABIN7466507)
抗原
See all MED19 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人
-
纯化方法
- Purified by antigen-affinity chromatography.
-
免疫原
- Recombinant protein encompassing a sequence within the center region of human MED19. The exact sequence is proprietary.
-
亚型
- IgG
-
-
-
-
应用备注
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
说明
-
Positive Control: Jurkat , Raji , NCI-H929
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.49 mg/mL
-
缓冲液
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
别名
- mediator complex subunit 19
-
背景
- Mediator complex subunit 19 , DT2P1G7 , LCMR1 , MED19AS,MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM]
-
分子量
- 26 kDa
-
基因ID
- 219541
-
UniProt
- A0JLT2
-
途径
- Regulation of Lipid Metabolism by PPARalpha
抗原
-